ES2059986T3 - Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion. - Google Patents

Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion.

Info

Publication number
ES2059986T3
ES2059986T3 ES90200532T ES90200532T ES2059986T3 ES 2059986 T3 ES2059986 T3 ES 2059986T3 ES 90200532 T ES90200532 T ES 90200532T ES 90200532 T ES90200532 T ES 90200532T ES 2059986 T3 ES2059986 T3 ES 2059986T3
Authority
ES
Spain
Prior art keywords
composition
pancreas
treatment
exocrine insufficiency
lipasa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90200532T
Other languages
English (en)
Inventor
Luc Oscar Julien Iliano
Simon Lodewijk Scharpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8202339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2059986(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2059986T3 publication Critical patent/ES2059986T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

DICHA COMPOSICION COMPRENDE COMO COMPONENTES ACTIVOS, UNA LIPASA MICROBIAL Y UN EXTRACTO DE PANCREAS DE MAMIFERO, Y UN PORTADOR O DILUYENTE FARMACEUTICAMENTE ACEPTABLE, PREFERIBLEMENTE LA LIPASA MICROBIAL ES LLEVADA A UNA ACTIVIDAD ESPECIFICA DE MAS DE 125.000 PREFERIBLEMENTE 600.000, Y MAS PREFERIBLEMENTE 1.500.000 FIP U/G.
ES90200532T 1989-03-08 1990-03-06 Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion. Expired - Lifetime ES2059986T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89200589 1989-03-08

Publications (1)

Publication Number Publication Date
ES2059986T3 true ES2059986T3 (es) 1994-11-16

Family

ID=8202339

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90200532T Expired - Lifetime ES2059986T3 (es) 1989-03-08 1990-03-06 Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion.

Country Status (4)

Country Link
EP (1) EP0387945B1 (es)
DE (1) DE69004301T2 (es)
DK (1) DK0387945T3 (es)
ES (1) ES2059986T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3593550B2 (ja) * 1991-07-01 2004-11-24 ノルトマルク アルツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 医薬品製造のためのリパーゼの使用
AU6221496A (en) * 1995-05-31 1996-12-18 Simon Lodewijk Scharpe Composition to improve digestibility and utilisation of nutr ients
WO2006044529A1 (en) 2004-10-14 2006-04-27 Altus Pharmaceuticals Inc. Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
US8071089B2 (en) 2005-11-01 2011-12-06 Bio-Cat, Inc. Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
WO2016126970A1 (en) * 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642853A1 (de) * 1986-12-16 1988-06-23 Ulrich Von Dr Ing Pidoll Arzneimittel

Also Published As

Publication number Publication date
EP0387945A1 (en) 1990-09-19
DK0387945T3 (da) 1993-12-20
DE69004301D1 (de) 1993-12-09
EP0387945B1 (en) 1993-11-03
DE69004301T2 (de) 1994-03-24

Similar Documents

Publication Publication Date Title
BR9711447A (pt) Uso de glp-1 an logos no tratamento de enfarte de mioc rdio
ES2052829T3 (es) Aminoetiltetralinas substituidas asi como sus analogos heterociclicos.
ES2044912T3 (es) Composiciones farmaceuticas dotadas de actividad secuestrante para los acidos biliares, conteniendo colestiramina como principio activo, y procedimiento para su preparacion.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
ES2181725T3 (es) Inhibidores de hiv proteasa.
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
DE59007178D1 (de) Verwendung alkylierter Polyethylenimine als gallensäureadsorbierende Arzneimittel sowie pharmazeutische Präparate.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES2082198T3 (es) Inhibidores de esteroide-sulfatasa.
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
ES2056206T3 (es) Derivados lactamicos de carbohidratos y su empleo en composiciones cosmeticas.
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
ES2082872T3 (es) Composiciones antiglaucoma que contienen 3-arilcarbonil-1-aminoalquil--1h-indol.
ES2054353T3 (es) Expresion de las alipoproteinas humanas ai-milano en levadura.
ES2061118T3 (es) N-oxidos de piridinas sustituidas en posiciones 2,4 y 2,5, procedimiento para su preparacion, asi como su utilizacion.
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
JO1610B1 (en) Tetrahydimidimidose compounds (1,4) benzodiazepine-2 thyonath anti-viral and anti-viral
IT1232318B (it) Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
ES2059986T3 (es) Una composicion para el tratamiento de la insuficiencia exocrina del pancreas, y el uso de dicha composicion.
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
ES2091249T3 (es) Analogos de iludina utilizables como agentes antitumorales.
ES2083374T3 (es) Derivados amidicos en posicion c63 de 34-des(acetilglucosaminil)-34-desoxi-teicoplaninas.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
ES2037278T3 (es) Tratamiento de la esterilidad.
ES2087279T3 (es) El uso de giberelinas para el tratamiento de la prostatitis y la psoriasis.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 387945

Country of ref document: ES